Skip to main content

Mayne Pharma — Deal History & Benchmarks

Total Deals
2
Across 1 therapeutic area
Total Deal Value
$523M
Cumulative transaction value
Most Active Year
2022
1 deal closed
Primary TA
Women's Health
100% of deal activity
Model Your Deal

Market Analysis

Mayne Pharma has been involved in 2 transactions totaling $523M across Women's Health. As both a licensor and licensee, they have demonstrated an active acquisition strategy.

PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.

or
Unlock Everything — $299/mo Pro

7-day money-back guarantee · Cancel anytime

Customize these benchmarks for your asset

Adjust phase, modality, competitive position, and 10+ other parameters.

Open Calculator

Frequently Asked Questions

How many deals has Mayne Pharma done?
Mayne Pharma has completed 2 verified transactions tracked in our database, spanning from 2022 to 2023. These deals have a combined value of $523M.
PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.

or
Unlock Everything — $299/mo Pro

7-day money-back guarantee · Cancel anytime

Related Benchmarks

Phase 2 Deal Benchmarks

View

Ready to Calculate Your Deal Terms?

Get instant, customized benchmarks based on real market data from 600+ biopharma licensing deals.

Start Calculating